View in EDS

Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy.

Saved in:
Bibliographic Details
Title: Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy.
Authors: Yin N; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China., Zhang Z; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China., Ge Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China., Zhao Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China., Gu Z; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China.; Zhengzhou University of Industrial Technology, Zhengzhou 450001, China., Yang Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China., Mao L; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China., Wei Z; International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China., Liu J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou 450001, China., Shi J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou 450001, China., Wang Z; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China.; International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.
Source: Science advances [Sci Adv] 2023 Jun 16; Vol. 9 (24), pp. eadf4098. Date of Electronic Publication: 2023 Jun 14.
Publication Type: Journal Article
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37315148
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yin+N%22">Yin N</searchLink>; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Z%22">Zhang Z</searchLink>; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China.<br /><searchLink fieldCode="AU" term="%22Ge+Y%22">Ge Y</searchLink>; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China.<br /><searchLink fieldCode="AU" term="%22Zhao+Y%22">Zhao Y</searchLink>; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China.<br /><searchLink fieldCode="AU" term="%22Gu+Z%22">Gu Z</searchLink>; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China.; Zhengzhou University of Industrial Technology, Zhengzhou 450001, China.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China.<br /><searchLink fieldCode="AU" term="%22Mao+L%22">Mao L</searchLink>; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China.<br /><searchLink fieldCode="AU" term="%22Wei+Z%22">Wei Z</searchLink>; International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou 450001, China.<br /><searchLink fieldCode="AU" term="%22Shi+J%22">Shi J</searchLink>; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou 450001, China.<br /><searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China.; International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101653440%22">Science advances</searchLink> [Sci Adv] 2023 Jun 16; Vol. 9 (24), pp. eadf4098. <i>Date of Electronic Publication: </i>2023 Jun 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101653440 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2375-2548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223752548%22">23752548 </searchLink><i>NLM ISO Abbreviation: </i>Sci Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37315148
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1126/sciadv.adf4098
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: eadf4098
    Titles:
      – TitleFull: Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yin N
      – PersonEntity:
          Name:
            NameFull: Zhang Z
      – PersonEntity:
          Name:
            NameFull: Ge Y
      – PersonEntity:
          Name:
            NameFull: Zhao Y
      – PersonEntity:
          Name:
            NameFull: Gu Z
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: Mao L
      – PersonEntity:
          Name:
            NameFull: Wei Z
      – PersonEntity:
          Name:
            NameFull: Liu J
      – PersonEntity:
          Name:
            NameFull: Shi J
      – PersonEntity:
          Name:
            NameFull: Wang Z
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 06
              Text: 2023 Jun 16
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2375-2548
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 24
          Titles:
            – TitleFull: Science advances
              Type: main
ResultId 1